APOL1-Mediated Kidney Disease (AMKD) Latest Advances

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: December 10, 2025

Purine Metabolism Regulates the Severity of APOL1 Nephropathy.

Journal: Journal of the American Society of Nephrology : JASN

Published: November 25, 2025

Update on APOL1 and chronic kidney diseases in children.

Journal: Pediatric nephrology (Berlin, Germany)

Published: November 24, 2025

Case report of a child with kidney disease: consideration of the risk of a single APOL1 G2 allele with a protective N264K variant on the G0 parental chromosome.

Journal: BMC nephrology

Published: November 17, 2025

APOL1-Mediated Kidney Disease (AMKD) Latest Advances

Find the Latest Research About APOL1-Mediated Kidney Disease (AMKD)

Clinical and genetic risk factors for apolipoprotein L1-mediated chronic kidney disease in people of African ancestry with HIV.

Clinical and genetic risk factors for apolipoprotein L1-mediated chronic kidney disease in people of African ancestry with HIV.

Differential regulation of basal and interferon-induced APOL1 gene expression in podocytes.

Differential regulation of basal and interferon-induced APOL1 gene expression in podocytes.

APOL1-Mediated Kidney Disease and the Emerging Era of Precision Therapy.

APOL1-Mediated Kidney Disease and the Emerging Era of Precision Therapy.

Beyond Genotype: Proteomic Risk Stratification for APOL1-Mediated Kidney Disease.

Beyond Genotype: Proteomic Risk Stratification for APOL1-Mediated Kidney Disease.

Albuminuria Changes as a surrogate endpoint in Apolipoprotein L1 Mediated Kidney Disease in Vanderbilt BioVU and the Million Veteran Program.

Albuminuria Changes as a surrogate endpoint in Apolipoprotein L1 Mediated Kidney Disease in Vanderbilt BioVU and the Million Veteran Program.

Chronic kidney disease risk stratification using a proteomic risk score in apolipoprotein L1-mediated kidney disease.

Chronic kidney disease risk stratification using a proteomic risk score in apolipoprotein L1-mediated kidney disease.

APOL1 kidney disease: a critical narrative review of molecular mechanisms, clinical heterogeneity, and the emerging therapeutic landscape.

APOL1 kidney disease: a critical narrative review of molecular mechanisms, clinical heterogeneity, and the emerging therapeutic landscape.

Oxidative Stress Potentiates a STAT1-APOL1 Feedforward Loop and Governs Disease Severity in APOL1-Mediated Kidney Disease.

Oxidative Stress Potentiates a STAT1-APOL1 Feedforward Loop and Governs Disease Severity in APOL1-Mediated Kidney Disease.

Modeling podocytopathies with kidney organoids.

Modeling podocytopathies with kidney organoids.

Purine Metabolism Regulates the Severity of APOL1 Nephropathy.

Purine Metabolism Regulates the Severity of APOL1 Nephropathy.

Update on APOL1 and chronic kidney diseases in children.

Update on APOL1 and chronic kidney diseases in children.

Case report of a child with kidney disease: consideration of the risk of a single APOL1 G2 allele with a protective N264K variant on the G0 parental chromosome.

Case report of a child with kidney disease: consideration of the risk of a single APOL1 G2 allele with a protective N264K variant on the G0 parental chromosome.